United States · FDA National Drug Code directory
Allergy Relief
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69168-413_706fa553-a089-4d9b-8e40-f814a6c4dc75
- Product NDC
- 69168-413
- Form
- CAPSULE, COATED
- Composition / generic term
- Fexofenadine HCl
- Labeler
- Allegiant Health
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210322
- Source listing expiry
- 20271231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 180 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 CAPSULE, COATED in 1 CARTON (69168-413-03) · 69168-413-03
- 120 CAPSULE, COATED in 1 BOTTLE (69168-413-06) · 69168-413-06
- 250 CAPSULE, COATED in 1 BOTTLE (69168-413-14) · 69168-413-14
- 30 CAPSULE, COATED in 1 BOTTLE (69168-413-30) · 69168-413-30
- 180 CAPSULE, COATED in 1 BOTTLE (69168-413-80) · 69168-413-80
- 90 CAPSULE, COATED in 1 BOTTLE (69168-413-82) · 69168-413-82
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →